Nektar Therapeutics

NASDAQ: NKTR · Real-Time Price · USD
27.43
0.17 (0.62%)
At close: Aug 18, 2025, 3:59 PM
27.01
-1.53%
Pre-market: Aug 19, 2025, 08:02 AM EDT

Nektar Therapeutics Revenue

Nektar Therapeutics reported an annual revenue of $98.43M, reflecting a 9.22% growth. For the quarter ending June 30, 2025, Nektar Therapeutics generated $11.18M in revenue.
Revenue (ttm)
98.43M
Revenue Growth
9.22%
Price / Sales Ratio
1.94
Revenue / Employee
1.61M
Employees
61
Market Cap
521.68M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Dec 31, 2024 98.43M +9.22%
Dec 31, 2023 90.12M -2.10%
Dec 31, 2022 92.06M -9.67%
Dec 31, 2021 101.91M -33.36%
Dec 31, 2020 152.91M +33.41%
Dec 31, 2019 114.62M -90.40%
Dec 31, 2018 1.19B +287.81%
Dec 31, 2017 307.71M +86.00%
Dec 31, 2016 165.44M -28.32%
Dec 31, 2015 230.78M +14.99%
Dec 31, 2014 200.71M +34.77%
Dec 31, 2013 148.92M +83.42%
Dec 31, 2012 81.19M +13.59%
Dec 31, 2011 71.48M -55.06%
Dec 31, 2010 159.04M +121.10%
Dec 31, 2009 71.93M -20.24%
Dec 31, 2008 90.19M -66.97%
Dec 31, 2007 273.03M +25.40%
Dec 31, 2006 217.72M +72.41%
Dec 31, 2005 126.28M +10.51%
Dec 31, 2004 114.27M +7.54%
Dec 31, 2003 106.26M +12.03%
Dec 31, 2002 94.84M +22.43%
Dec 31, 2001 77.47M +50.05%
Dec 31, 2000 51.63M +24.83%
Dec 31, 1999 41.36M +89.76%
Dec 31, 1998 21.8M +34.13%
Dec 31, 1997 16.25M +135.49%
Dec 31, 1996 6.9M +102.94%
Dec 31, 1995 3.4M +100.00%
Dec 31, 1994 1.7M n/a
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.